Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2). (2019)
Attributed to:
Identifying the prevalence of antibodies to neuronal membrane targets in first episode psychosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-019-3336-1
PubMed Identifier: 31174586
Publication URI: http://europepmc.org/abstract/MED/31174586
Type: Journal Article/Review
Volume: 20
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215